All Videos Expert Interviews Medical World News Podcasts Case Based Roundtable Series Case of the Quarter EyeView Grand Rounds Insights Rapid Readout Viewpoints What’s Your WhEYE?

Conference Coverage Conference Listing

Events

Digital Edition Europe Ophthalmology Times Modern Retina Supplements and Featured Publications

CME Partners Subscribe

Cataract Therapeutics

Clinical Diagnosis Clinical Diagnosis Clinical Diagnosis

Interventional Glaucoma Interventional Glaucoma Interventional Glaucoma Interventional Glaucoma

OCT

Ocular Allergy

Ocular Surface Disease

Practice Management Practice Management

Presbyopia

Ptosis

Refractive Refractive

Understanding Antibiotic Resistance

Workplace

Spotlight -

Retina

Cataract Therapeutics

Clinical Diagnosis Clinical Diagnosis Clinical Diagnosis

Interventional Glaucoma Interventional Glaucoma Interventional Glaucoma Interventional Glaucoma

OCT

Ocular Allergy

Ocular Surface Disease

Practice Management Practice Management

Presbyopia

Ptosis

Refractive Refractive

Understanding Antibiotic Resistance

Workplace

Article

April 27, 2004

VIM Trial results favor PDT for small, subfoveal minimally classic,AMD-related CNV

Verteporfin (Visudyne) photodynamic therapy (PDT) using either a reducedor standard light fluence rate appears to be beneficial for patients withrelatively small, subfoveal minimally classic CNV associated with age-relatedmacular degeneration (AMD), said Philip J. Rosenfeld, MD.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!